unknown
Stage
About
Aleva Neurotherapeutics designs, manufactures and commercialises directional deep brain stimulation (DBS) systems, including the directSTIM™ system with a 24‑contact directional lead and MICC generator, for the treatment of Parkinson’s disease and essential tremor. The company develops medical devices and provides clinical training and support to neurologists and neurosurgeons.
Explore Aleva Neurotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.